PALM BEACH GARDENS, Fla.—MMC International has announced the release and availability of the 13th Edition of Trends Shaping U.S. Pharmaceutical Industry Strategies report by healthcare industry expert and award winning author Edmund L. Valentine.
The 13th Edition of MMC's "Trends" report is designed to challenge conventional thinking, fight "Group Think", inject fresh/different ways of looking at pharmaceuticals, and question product development, marketing, business development, and company strategies. It is an effective tool for the orientation of senior management employees new to the pharmaceuticals industry and serves as an excellent reference source for presentations and issues discussions.
The 13th Edition of "Trends" provides insights to how the transformation of the respective United States healthcare industry interrelated market segments/stakeholders will redefine how drugs are identified, developed, reimbursed, launched, marketed, prescribed, dispensed, and taken by patients. The period to 2020 presents opportunities for companies to redefine industry norms in select therapeutic and/or product categories to create a competitive advantage. Strategically managed companies will anticipate and capitalize on industry change, innovate and prosper; the remainder will be broken up, acquired, merged or driven out of business.
Purchaser of the 13th Edition of the Trends Shaping U.S. Pharmaceutical Industry Strategies report will be better positioned to: 1) capitalize on industry change, 2) positively contribute to their company's success, and 3) increase shareholder returns.